The Efficacy and Safety of Docetaxel Plus Prednisone with or without Lenalidomide in Patients with Castrate-Resistant Prostate Cancer: The MAINSAIL Trial

Autor:	P. Vinall, D. P. Petrylak
Rok vydání:	2012
Předmět:	Oncology medicine.medical_specialty Docetaxel Prednisone business.industry Internal medicine medicine Castrate-resistant prostate cancer In patient business medicine.drug Lenalidomide
Zdroj:	MD Conference Express. 12:10-11
ISSN:	2155-756X 1559-8977
DOI:	10.1177/155989771215006
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::78e3c3c72ef96f9cc859eb6fde71143b https://doi.org/10.1177/155989771215006 Zobrazit plný text záznamu Plný text ve formátu PDF